Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Phase 1 Completed
18 enrolled
TraveraRTGx
Completed
72 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
Study of DF6215 in Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
215 enrolled 30 charts
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
Completed
64 enrolled
PREPARE
Phase NA Completed
792 enrolled
RAF/MEK
Phase 1 Completed
104 enrolled
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies
Phase 1/2 Completed
18 enrolled
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
Phase 2 Completed
25 enrolled 11 charts
A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors
Phase 1 Completed
6 enrolled
INOVOLINE
Phase NA Completed
101 enrolled
Study of ESG401 in Adults With Solid Tumors
Phase 1/2 Completed
156 enrolled
AMPLIFY-201
Phase 1 Completed
25 enrolled 15 charts
EARN
Phase NA Completed
33 enrolled
A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1/2 Completed
87 enrolled 22 charts
GLIMMER-01
Phase 1/2 Completed
69 enrolled 13 charts
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Phase 1/2 Completed
307 enrolled 27 charts
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Phase 1/2 Completed
145 enrolled 47 charts
CNSI-Fe(II)
Phase 1 Completed
19 enrolled 47 charts
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Completed
7 enrolled
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
Phase 1 Completed
54 enrolled
PRIORITY
Completed
346 enrolled 9 charts
A Study of CDX-585 in Patients With Advanced Malignancies
Phase 1 Completed
20 enrolled
EXODIAG
Phase NA Completed
71 enrolled
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
Continued Access to RXDX-105
Phase 1 Completed
3 enrolled
CAR T Cells in Mesothelin Expressing Cancers
Phase 1 Completed
65 enrolled 14 charts
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Completed
58 enrolled
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers
Phase 1/2 Completed
62 enrolled 29 charts
Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1
Phase 1 Completed
10 enrolled
PREFER
Completed
1,429 enrolled
ACTolog
Phase 1 Completed
38 enrolled
A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Phase 1 Completed
112 enrolled
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Phase NA Completed
128 enrolled 24 charts
REMOVE
Phase NA Completed
136 enrolled
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
Phase 1 Completed
121 enrolled
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
Phase 1/2 Completed
79 enrolled
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
139 enrolled 36 charts
ROOT
Completed
167 enrolled
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Phase 1 Completed
12 enrolled
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Phase 1 Completed
279 enrolled
Study of Continuous OSI-906 Dosing
Phase 1 Completed
95 enrolled
Study of Intermittent OSI-906 Dosing
Phase 1 Completed
79 enrolled
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Phase 1/2 Completed
26 enrolled 14 charts
IVY
Phase 1 Completed
353 enrolled
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Phase 1 Completed
29 enrolled